Trial intelligence / Profile preview

Omega-3-acid ethyl esters and vascular endothelial function in hyperlipidemia

jRCT1080223214Phase 4

Sponsor
Takeda
Start
May 2016
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, single-arm trial of omega-3-acid triglycerides in hyperlipidemia and hypertriglyceridemia, sponsored by Takeda.

02

Drugs

omega-3-acid triglycerides
03

Conditions

hyperlipidemiahypertriglyceridemia

Beyond the preview

Go deeper on jRCT1080223214.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080223214.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call